AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4191 out of 4871 analysts
Average Return
-6.52%
Win Rate
40%6 out of 15
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-01 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-28 -
2024-07-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-20 -
2024-03-20
Buy
Vertex Pharmaceuticals IncVRTX
+15.53%$346.36$400.16
2023-05-02 -
2024-05-02
Buy
Biomarin Pharmaceutical IncBMRN
+10.03%$92.08$82.84
2023-03-20 -
2023-10-23
Sell

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alnylam Pharmaceuticals IncALNY
2Buy$310.00+19.51%Maintains
4 months ago
Regeneron Pharmaceuticals IncREGN
2Buy$1,070.00+76.68%Maintains
4 months ago
Arrowhead Pharmaceuticals IncARWR
2Hold$24.00+66.44%Maintains
5 months ago
Biohaven LtdBHVN
2Buy$66.00+188.84%Maintains
7 months ago
Biomarin Pharmaceutical IncBMRN
4Buy$90.00+45.09%Maintains
8 months ago
Vertex Pharmaceuticals IncVRTX
4Buy$390.00N/AMaintains
2 years ago
Intellia Therapeutics IncNTLA
1Buy$54.00N/AInitiates Coverage On
2 years ago
Beam Therapeutics IncBEAM
1Hold$37.00N/AInitiates Coverage On
2 years ago
Allogene Therapeutics IncALLO
1Hold$6.00N/AInitiates Coverage On
2 years ago
Crispr Therapeutics AgCRSP
1Hold$44.00N/AInitiates Coverage On
2 years ago
Ionis Pharmaceuticals IncIONS
1Sell$31.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.